ciprofloxacin has been researched along with Angiohemophilia in 2 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castaman, G | 2 |
| Lattuada, A | 1 |
| Mannucci, PM | 1 |
| Rodeghiero, F | 2 |
2 other studies available for ciprofloxacin and Angiohemophilia
| Article | Year |
|---|---|
Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor.
Topics: Bleeding Time; Ciprofloxacin; Collagen; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Humans | 1995 |
Acquired transitory von Willebrand syndrome with ciprofloxacin.
Topics: Adult; Ciprofloxacin; Female; Humans; Male; von Willebrand Diseases | 1994 |